Completed PHASE4 INTERVENTIONAL 6-arm NCT00793663

Depth of Hypnosis and Postoperative Nausea and Vomiting During Xenon Anaesthesia (XABP)

1) The Effect of Xenon and Sevoflurane on Hypnosis Monitors. 2) Prevention of Postoperative Nausea and Vomiting. 3) Rescue Treatment of Established Postoperative Nausea and Vomiting. Sevoflurane.

Sponsor: Air Liquide Santé International

Conditions Anaesthetics Gases, Xenon Anaesthetics Volatile, Sevoflurane Depth of Anaesthesia Postoperative Nausea Postoperative Vomiting

Interventions Dexamethasone NaCl Ondansetron Sevoflurane Xenon

Updated 5 times since 2017 Last updated: May 16, 2011 Started: Nov 30, 2008 Primary completion: Apr 30, 2011 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Anaesthetics Gases, Xenon and Anaesthetics Volatile, Sevoflurane, this trial is completed. The trial is conducted by Air Liquide Santé International and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Air Liquide Santé International
RWTH Aachen University

Data source: RWTH Aachen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aachen, Germany